Worldwide, there is a growing appeal in the pharmaceutical industry for recombinant technologies that help alleviate, and eventually replace, the use of animal resources for endotoxin testing purposes.

Adoption of recombinant tests, like the PyroGene^® rFC Assay are on the rise. Since its launch in 2003, Lonza’s PyroGene^® rFC Assay has been used by hundreds of companies in over 30 countries. QC professionals can meet the demands of endotoxin testing with a reliable and sustainable method, while protecting a natural resource.

In this webinar you’ll learn about:

• The history of the PyroGene^® Recombinant Factor C Assay
• The need for an alternative method
• Recombinant Factor C validation data and results
• Regulatory considerations

• QC lab managers/supervisors/directors 
• QC lab analysts
• QA managers
• Process development scientists
• Method development scientists
• Sustainability Managers